ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Claritas and CMAX Clinical sign agreement for Phase 1 R-107 clinical study
April 23, 2021Claritas Pharmaceuticals and CMAX Clinical Research have signed an agreement to conduct a Phase 1 clinical study of R-107. -
Claritas to expand Covid-19 trial to include sepsis treatment
April 12, 2021Claritas Pharmaceuticals is set to expand its development programme for R-107 to include the treatment of Covid-19 related sepsis, which is the leading cause of death in infected patients. -
Claritas and Salzman to create nitric oxide-releasing compound for Covid-19
March 05, 2021Claritas Pharmaceuticals (formerly Kalytera Therapeutics) and Salzman Group (SG) have entered a strategic collaboration agreement to accelerate the development of Claritas’ nitric oxide-releasing compound, R-107, for the treatment of Covid-19 ...
Pharma Sources Insight January 2025
